Close Menu

The Scan

This Week in Nature

In Nature this week: genomic factors that influence glioblastoma response to anti-PD-1 therapy, sequencing test for infectious disease, and more.

A report from the Personalized Medicine Coalition finds that more than 40 percent of new drugs approved in the US in 2018 were personalized medicines.

Plan Protested

Researchers in Hungary are protesting a plan that would increase the government's influence on research funding, the Associated Press reports.

The Right Note

Genes and training appear necessary for perfect pitch, according to Cosmos.

In Nucleic Acids Research this week: microRNAs influence cell type transitions in triple-negative breast cancers, oxidative DNA damage patterns in yeast, and more.

Starting Up Again

ScienceInsider reports that some risky flu studies that came to a halt a few years back may soon resume.

On Butterfly Wings

A genetic analysis finds that three genomic regions influence mate choice in two Heliconius butterfly species, as Smithsonian magazine reports.

For Smarts?

A trio of researchers writes at Stat News that while editing embryos to improve IQ is not yet possible, there's already a way to predict which embryos might be the smartest.

This Week in PNAS

In PNAS this week: blood plasma lipidome analysis of Ebola patients, genome organization of the malaria-causing parasite, and more.

A commentary appearing in Nature calls for the establishment of a research policy board in the US.

Sangamo Therapeutics has announced preliminary results from its gene-editing trial, the Associated Press reports.

Make 'Em Hardier

The Financial Times looks into the use of gene editing within agriculture.

This Week in PLOS

In PLOS this week: map of breakpoints in individuals with complex chromosomal rearrangements, sequence of virus that infects African armyworm, and more.

'Bout a Dozen

The National Institutes of Health has asked a federal oversight office to review a dozen allegations of foreign influence on US research, Stat News reports.

Who Knew What When?

Technology Review reports that Stanford University is investigating what its faculty members knew about He Jiankui's effort to edit the genomes of human embryos.

According to Nature News, researchers in Germany, Hungary, and Sweden have lost access to Elsevier journals as contract talks stall.

This Week in Science

In Science this week: discussion of combining immunotherapies with targeted treatments, and more.

And Science?

Chemical & Engineering News writes that President Donald Trump's State of the Union address mostly disappointed science advocates.

Only a Handful

A new analysis by Norwegian researchers finds few open-access journals meet Plan S requirements, according to ScienceInsider.

A new Mars rover slated to touch down there in 2021 has been named after Rosalind Franklin, Agence France Presse reports.

This Week in Nature

In Nature this week: new CRISPR nuclease described, gut bacteria reference, and more.

Speed Search

Researchers from the University of Oxford have devised an approach to quickly search viral and bacterial genomes, according to the Atlantic.

NPE Support

Fox10 in Phoenix reports on a Facebook-based support group for people who learn through direct-to-consumer genetic testing that a parent isn't a biological parent.

Wired reviews three different DNA tests using two dogs to find they gave varying results.

This Week in Cell

In Cell this week:  factors that regulate the differentiation of T helper type 2, structural variants teased out from long-read sequenced human genomes, and more.


Nature News reports that female scientists setting up their first labs tend to have lower salaries and smaller staffs than their male peers.

A new analysis by Northwestern University researchers finds that female and male first-time PIs receive differing amounts of funding.

Some 43 percent of new mothers and 23 percent of new fathers leave full-time employment in STEM in the years after having a child, Science Careers says.

STEM professors' views on intelligence affect students' success, a new study finds.